Empowering Healthcare through People, Process,
& Technology
Providing reliable and consistent professional services to healthcare industries with a specialization in life sciences and pharmaceuticals.
Transforming and Inspiring Excellence Through Specialized Services
Our Services
Program & Project Management
Providing project management expertise to effectively manage clinical studies, program and product launches, systems and process implementations, and change management including training.
Implementation Experts
Leveraging implementation experts with the knowledge, experience, and skills to partner with clients to implement and launch systems and processes to advance drug and therapeutics development.
Data Lifecycle Management
Integrating, managing, and harnessing the power of data to streamline information to ensure compliance, accuracy, completeness, security, timeliness, and accessibility.
Clinical Studies
Utilizing experienced Clinical Managers, In-house CRAs/CTAs, and Site Monitors to effectively execute and manage clinical trials.
Lab Professionals
Engaging laboratory experts to effectively conduct, process, analyze, and manage samples for research, testing and drug development.
Market & Patient Access
Navigating regulatory, reimbursement, and distribution pathways to maximize patient access while maintaining commercial viability.
About Us
Headquartered in McLean, VA, and serving clients nationwide, BioPharma360 is a team of professionals with over 35 years of combined experience across the healthcare, life sciences, and pharmaceutical sectors. Our expertise spans the full lifecycle of drug, system, and process development, from clinical trials to market launch and patient access.
With our trusted team of experts and strong network of partners, we are committed to delivering tailored, innovative solutions that not only drive success but also ensure lasting, positive outcomes.
Featured News
The Future Of Medicine: How AI Is Revolutionizing Pharma
The artificial intelligence (AI) revolution seems to pick up pace from one week to the next, but what does it mean for the pharmaceutical sector?
FDA panel makes the call on much-anticipated Alzheimer’s drug donanemab
A Food and Drug Administration advisory panel on Monday endorsed the experimental Alzheimer’s drug donanemab, which studies showed slowed early stages of the fatal mind-robbing
InnovationRx: Tarsus Pharmaceuticals Takes Aim At Disease-Causing Bugs
Around 25 million Americans are affected by the eye disease Demodex blepharitis, which is caused by small mites that make their way into the eyelid. This causes chronic
